399 related articles for article (PubMed ID: 19695854)
21. Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment.
Miettinen TA; Gylling H;
Clin Chim Acta; 2007 Apr; 379(1-2):53-8. PubMed ID: 17258182
[TBL] [Abstract][Full Text] [Related]
22. Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men.
Strandberg TE; Gylling H; Tilvis RS; Miettinen TA
Atherosclerosis; 2010 May; 210(1):282-7. PubMed ID: 19962145
[TBL] [Abstract][Full Text] [Related]
23. Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients.
Faltaos DW; Urien S; Carreau V; Chauvenet M; Hulot JS; Giral P; Bruckert E; Lechat P
Fundam Clin Pharmacol; 2006 Jun; 20(3):321-30. PubMed ID: 16671968
[TBL] [Abstract][Full Text] [Related]
24. Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics.
Nagy K; Jakab A; Pollreisz F; Bongiorno D; Ceraulo L; Averna MR; Noto D; Vékey K
Rapid Commun Mass Spectrom; 2006; 20(16):2433-40. PubMed ID: 16841361
[TBL] [Abstract][Full Text] [Related]
25. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men.
Miettinen TA; Tilvis RS; Kesäniemi YA
Metabolism; 1989 Feb; 38(2):136-40. PubMed ID: 2913464
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments.
Miettinen TE; Kiviluoto T; Taavitsainen M; Vuoristo M; Miettinen TA
Hepatology; 1998 Mar; 27(3):649-55. PubMed ID: 9500689
[TBL] [Abstract][Full Text] [Related]
27. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
[TBL] [Abstract][Full Text] [Related]
28. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome.
Hallikainen M; Kolehmainen M; Schwab U; Laaksonen DE; Niskanen L; Rauramaa R; Pihlajamäki J; Uusitupa M; Miettinen TA; Gylling H
Clin Chim Acta; 2007 Aug; 383(1-2):126-32. PubMed ID: 17573060
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan.
Inoue T; Taguchi I; Abe S; Toyoda S; Sakuma M; Node K
J Clin Pharm Ther; 2011 Feb; 36(1):103-10. PubMed ID: 21198725
[TBL] [Abstract][Full Text] [Related]
30. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
31. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment.
Miettinen TA; Gylling H
Eur J Clin Invest; 2003 Nov; 33(11):976-82. PubMed ID: 14636301
[TBL] [Abstract][Full Text] [Related]
33. Noncholesterol Sterols as Surrogate Markers in Patients with Severe Alcoholic Hepatitis.
Sahlman P; Nissinen M; Simonen P; Färkkilä M
Lipids; 2018 Mar; 53(3):323-334. PubMed ID: 29663389
[TBL] [Abstract][Full Text] [Related]
34. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
35. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
Gylling H; Miettinen TA
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
[TBL] [Abstract][Full Text] [Related]
36. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics.
Simonen PP; Gylling H; Miettinen TA
Obes Res; 2002 May; 10(5):328-35. PubMed ID: 12006631
[TBL] [Abstract][Full Text] [Related]
37. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
[TBL] [Abstract][Full Text] [Related]
38. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
Márk L; Paragh G
Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition.
Pakarinen MP; Kurvinen A; Gylling H; Miettinen TA; Pesonen M; Kallio M; Koivusalo AI; Nissinen MJ
Dig Liver Dis; 2010 Aug; 42(8):554-9. PubMed ID: 20538532
[TBL] [Abstract][Full Text] [Related]
40. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
